The negative effect of dyslipidemia on SBRS observed is consistent with our previous studies done in ApoE−/− mice, with the effects of dyslipidemia observed in humans as well as in LDL-receptor knockout mice, as very recently reported by Campos et al[34]. This evidence concerns the gene LDLR and metabolic syndrome.